Pro-Dex, Inc.

PDEX Healthcare Medical Instruments & Supplies

Pro-Dex, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $77.5 million, up 16.5% from fiscal 2025.

Revenue
+11.0%
EPS
−33.6%
Free cash flow
+177.8%
Total debt
+42.2%

Quarter to September 2026, against a year earlier

62.75 1.55 +2.53%
Market cap
$195.8M
P/E
16.4×
Fwd P/E
18.8×
Dividend yield
—
F-score
6/9
Altman Z
7.38
Beneish M
−1.11
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Piotroski F-Score

+8 more TTM periods

7 5 6 5
ROE
30.87% 29.83% 32.43% 26.48%
ROA
18.49% 17.24% 20.14% 17.08%
ROIC
17.38% 13.92% 15.75% 17.22%
Return on Tangible Assets
23.74% 23.72% 26.47% 22.97%
Average Days of Receivables
91.88 96.70 102.73 85.26
Free Cash Flow per Share
1.85 2.18 2.10 3.33
Free Cash Flow
6.02 6.97 6.76 10.69
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026